News Release
In a first for the pharmaceutical industry, Lilly ICOS LLC, maker of levitra ® (vardenafil), is committing to pay for a competing erectile dysfunction (ED) product if men are not satisfied with levitra. Through a limited-time special offer called "The levitra Promise," men with ED who have never used levitra can receive a voucher for a free trial. If they like levitra, they can get a second trial at no charge. If they are not satisfied with levitra, Lilly ICOS will pay for a trial of a competing oral ED product as prescribed by their doctor.
The levitra Promise launches nationwide today through a print and broadcast ad campaign that features a twist on the signature levitra advertising image of a couple watching a sunset while seated in side-by-side bathtubs. This time, the bathtubs are empty and the tagline reads, "Looks Like Someone Discovered The levitra Promise." levitra is the only oral ED treatment clinically proven to both act fast and work up to 36 hours for most men. In addition, levitra can be taken without regard to food. These benefits allow a man and his partner to relax and let intimacy happen when the moment is right for them.
"We are so confident that men with ED will appreciate the benefits of levitra that we’re willing to go as far as offering to pay for our competitors’ products if they are not satisfied," said Paul Clark, chairman and CEO of ICOS Corporation. "Because levitra provides a broad window of opportunity to choose the moment that’s right for a man and his partner, we believe that most men will be satisfied with their experience with levitra, and will want to stick with it beyond the free trial."
Men with ED can download a free levitra voucher and the levitra Promise Card from the levitra Web site, www.levitra.com. A man would then talk to his doctor to determine if levitra is right for him. If his doctor writes him a prescription for levitra, he would take it and the free levitra voucher to his local pharmacy to get a free trial. After taking levitra as directed by his doctor, the man would fill out the levitra Promise Card and send it, along with a copy of his pharmacy receipt from the free voucher to:
If he decides that levitra is the treatment for him, Lilly ICOS will send him another voucher for an additional sample of levitra tablets, as prescribed by his doctor. If he is not satisfied with levitra, the company will send him a voucher for a trial of the oral ED treatment (PDE5 inhibitor) of his choice, as prescribed by his doctor. The levitra Promise is a limited time offer, and Lilly ICOS reserves the right to end the promotion at any time. Men should note: only a doctor or other healthcare professional can determine if an ED medication is right for an individual patient.
What 36 Hours Means for Men with ED
Treating ED is about more than helping a man achieve an erection, according to noted sexologist Marian E. Dunn, Ph.D., clinical associate professor and director of the Center for Human Sexuality, department of Psychiatry, State University of New York, Health Science Center, Brooklyn.
"Today, my patients tell me they want a treatment that allows them spontaneity in their relationship and time to connect as a couple," said Dunn. "Men who have ED already feel a great deal of pressure from their condition and from the need to plan intimacy. So men and their partners want a treatment option that will reduce time pressure."
A recent survey of 300 current levitra users supports Dunn’s conclusion and provides insight on why many men with ED are choosing levitra. According to the survey results, more than 80 percent of respondents indicated that intimacy was best when there are no time constraints and when there is no need to plan the moment aside from taking the pill. Further, 77 percent of men surveyed indicated that with levitra, they didn’t have to worry about being intimate within a certain period of time. 1
levitra, approved by the FDA in November 2003 for the treatment of erectile dysfunction, is the only oral ED treatment shown to improve erectile function up to 36 hours in most men. levitra can be taken without regard to food. The absorption of levitra is not reduced by food, including high-fat foods. levitra is currently available in approximately 70 countries, including Australia, Brazil, Mexico, Canada, the United States and countries throughout Europe. More than two million patients worldwide have been treated with levitra since its first introduction in February 2003.
levitra is available by prescription only and is not for everyone. Men taking nitrates, often used for chest pain, or certain alpha-blockers for prostate problems or Pharmacy Masculino Para Que Sirve levitra wann nehmen What Happens If A Woman Accidentally Takes , should not take levitra. Such combinations could cause a sudden, unsafe drop in blood pressure.
Men should discuss their health status with their doctors to ensure levitra is right for them and that they are healthy enough for sexual activity.
The most common side effects with levitra were headache, upset stomach, delayed backache and muscle ache. Although rare, men who experience an erection for more than four hours should seek immediate medical attention. Men should not drink alcohol in excess with levitra. levitra studies were not designed to assess multiple intercourse attempts after a single dose.
ED is defined as the consistent inability to attain and maintain an erection sufficient for sexual intercourse. ED affects an estimated 152 million men and their partners worldwide. 2 Experts believe that 80 - 90 percent of ED cases are related to a physical or medical condition, like diabetes, cardiovascular diseases, and prostate cancer treatment, while 10 - 20 percent are due to psychological causes. 3,4 In many cases, however, both psychological and physical factors contribute to the condition. 5
Lilly ICOS LLC, a joint venture between ICOS Corporation (Nasdaq: ICOS) and Eli Lilly and Company (NYSE: LLY), developed vardenafil for the treatment of erectile dysfunction.
Lilly, a leading innovation-driven corporation is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.
ICOS Corporation, a biotechnology company, is dedicated to bringing innovative therapeutics to patients. Headquartered in Bothell, Wash., ICOS is marketing its first product, levitra (vardenafil), for the treatment of erectile dysfunction. ICOS is working to develop treatments for serious unmet medical conditions such as chronic obstructive pulmonary disease, cancer and inflammatory diseases.
Except for historical information contained herein, this press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on current expectations, estimates and projections about the industry, management beliefs and certain assumptions made by the management of ICOS and Lilly. Investors are cautioned that matters subject to forward-looking statements involve risks and uncertainties, including economic, competitive, governmental, technological, legal and other factors discussed in the two companies' respective filings with the Securities and Exchange Commission, which may affect the business and prospects of the two companies and Lilly ICOS. Results and the timing and outcome of events may differ materially from those expressed or implied by the forward-looking statements in this press release. More specifically, there can be no assurance that levitra will achieve commercial success or that competing products will not pre-empt market opportunities that might exist for the product.
If he decides that levitra is the treatment for him, Lilly ICOS will send him another voucher for an additional sample of levitra tablets, as prescribed by his doctor. If he is not satisfied with levitra, the company will send him a voucher for a trial of the oral ED treatment (PDE5 inhibitor) of his choice, as prescribed by his doctor. The levitra Promise is a limited time offer, and Lilly ICOS reserves the right to end the promotion at any time. Men should note: only a doctor or other healthcare professional can determine if an ED medication is right for an individual patient.
News Release
In a first for the pharmaceutical industry, Lilly ICOS LLC, maker of levitra ® (vardenafil), is committing to pay for a competing erectile dysfunction (ED) product if men are not satisfied with levitra. Through a limited-time special offer called "The levitra Promise," men with ED who have never used levitra can receive a voucher for a free trial. If they like levitra, they can get a second trial at no charge. If they are not satisfied with levitra, Lilly ICOS will pay for a trial of a competing oral ED product as prescribed by their doctor.
The levitra Promise launches nationwide today through a print and broadcast ad campaign that features a twist on the signature levitra advertising image of a couple watching a sunset while seated in side-by-side bathtubs. This time, the bathtubs are empty and the tagline reads, "Looks Like Someone Discovered The levitra Promise." levitra is the only oral ED treatment clinically proven to both act fast and work up to 36 hours for most men. In addition, levitra can be taken without regard to food. These benefits allow a man and his partner to relax and let intimacy happen when the moment is right for them.
"We are so confident that men with ED will appreciate the benefits of levitra that we’re willing to go as far as offering to pay for our competitors’ products if they are not satisfied," said Paul Clark, chairman and CEO of ICOS Corporation. "Because levitra provides a broad window of opportunity to choose the moment that’s right for a man and his partner, we believe that most men will be satisfied with their experience with levitra, and will want to stick with it beyond the free trial."
Men with ED can download a free levitra voucher and the levitra Promise Card from the levitra Web site, www.levitra.com. A man would then talk to his doctor to determine if levitra is right for him. If his doctor writes him a prescription for levitra, he would take it and the free levitra voucher to his local pharmacy to get a free trial. After taking levitra as directed by his doctor, the man would fill out the levitra Promise Card and send it, along with a copy of his pharmacy receipt from the free voucher to:
If he decides that levitra is the treatment for him, Lilly ICOS will send him another voucher for an additional sample of levitra tablets, as prescribed by his doctor. If he is not satisfied with levitra, the company will send him a voucher for a trial of the oral ED treatment (PDE5 inhibitor) of his choice, as prescribed by his doctor. The levitra Promise is a limited time offer, and Lilly ICOS reserves the right to end the promotion at any time. Men should note: only a doctor or other healthcare professional can determine if an ED medication is right for an individual patient.
What 36 Hours Means for Men with ED
Treating ED is about more than helping a man achieve an erection, according to noted sexologist Marian E. Dunn, Ph.D., clinical associate professor and director of the Center for Human Sexuality, department of Psychiatry, State University of New York, Health Science Center, Brooklyn.
"Today, my patients tell me they want a treatment that allows them spontaneity in their relationship and time to connect as a couple," said Dunn. "Men who have ED already feel a great deal of pressure from their condition and from the need to plan intimacy. So men and their partners want a treatment option that will reduce time pressure."
A recent survey of 300 current levitra users supports Dunn’s conclusion and provides insight on why many men with ED are choosing levitra. According to the survey results, more than 80 percent of respondents indicated that intimacy was best when there are no time constraints and when there is no need to plan the moment aside from taking the pill. Further, 77 percent of men surveyed indicated that with levitra, they didn’t have to worry about being intimate within a certain period of time. 1
levitra, approved by the FDA in November 2003 for the treatment of erectile dysfunction, is the only oral ED treatment shown to improve erectile function up to 36 hours in most men. levitra can be taken without regard to food. The absorption of levitra is not reduced by food, including high-fat foods. levitra is currently available in approximately 70 countries, including Australia, Brazil, Mexico, Canada, the United States and countries throughout Europe. More than two million patients worldwide have been treated with levitra since its first introduction in February 2003.
levitra is available by prescription only and is not for everyone. Men taking nitrates, often used for chest pain, or certain alpha-blockers for prostate problems or L Arginine Combined With Pharmacy generic levitra vardenafil 2.5mg Acheter En Ligne Au Maroc , should not take levitra. Such combinations could cause a sudden, unsafe drop in blood pressure.
Men should discuss their health status with their doctors to ensure levitra is right for them and that they are healthy enough for sexual activity.
The most common side effects with levitra were headache, upset stomach, delayed backache and muscle ache. Although rare, men who experience an erection for more than four hours should seek immediate medical attention. Men should not drink alcohol in excess with levitra. levitra studies were not designed to assess multiple intercourse attempts after a single dose.
ED is defined as the consistent inability to attain and maintain an erection sufficient for sexual intercourse. ED affects an estimated 152 million men and their partners worldwide. 2 Experts believe that 80 - 90 percent of ED cases are related to a physical or medical condition, like diabetes, cardiovascular diseases, and prostate cancer treatment, while 10 - 20 percent are due to psychological causes. 3,4 In many cases, however, both psychological and physical factors contribute to the condition. 5
Lilly ICOS LLC, a joint venture between ICOS Corporation (Nasdaq: ICOS) and Eli Lilly and Company (NYSE: LLY), developed vardenafil for the treatment of erectile dysfunction.
Lilly, a leading innovation-driven corporation is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.
ICOS Corporation, a biotechnology company, is dedicated to bringing innovative therapeutics to patients. Headquartered in Bothell, Wash., ICOS is marketing its first product, levitra (vardenafil), for the treatment of erectile dysfunction. ICOS is working to develop treatments for serious unmet medical conditions such as chronic obstructive pulmonary disease, cancer and inflammatory diseases.
Except for historical information contained herein, this press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on current expectations, estimates and projections about the industry, management beliefs and certain assumptions made by the management of ICOS and Lilly. Investors are cautioned that matters subject to forward-looking statements involve risks and uncertainties, including economic, competitive, governmental, technological, legal and other factors discussed in the two companies' respective filings with the Securities and Exchange Commission, which may affect the business and prospects of the two companies and Lilly ICOS. Results and the timing and outcome of events may differ materially from those expressed or implied by the forward-looking statements in this press release. More specifically, there can be no assurance that levitra will achieve commercial success or that competing products will not pre-empt market opportunities that might exist for the product.
Lilly, a leading innovation-driven corporation is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.
Headquartered in Bothell, Wash.
09.05.2023 06:08:07
2023-05-09 06:08:07